Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson's and Alzheimer's Diseases as Disease Modifying Agents

por Youdim, Moussa B. H.
Publicado 2010

Multi Target Neuroprotective and Neurorestorative Anti-Parkinson and Anti-Alzheimer Drugs Ladostigil and M30 Derived from Rasagiline

por Youdim, Moussa B.H.
Publicado 2013

Why Do We Need Multifunctional Neuroprotective and Neurorestorative Drugs for Parkinson’s and Alzheimer’s Disorders?

por Youdim, Moussa B. H.
Publicado 2010

The Neuroprotective Activities of the Novel Multi-Target Iron-Chelators in Models of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis and Aging

por Kupershmidt, Lana, Youdim, Moussa B. H.
Publicado 2023

Regional siderosis: a new challenge for iron chelation therapy

por Cabantchik, Zvi Ioav, Munnich, Arnold, Youdim, Moussa B., Devos, David
Publicado 2013

Neuroprotection and Neuroregeneration in Alzheimer's Disease

por Sugaya, Kiminobu, Youdim, Moussa B. H., Nordberg, Agneta, Rao, K. S. Jagannatha
Publicado 2012

Selegiline: a molecule with innovative potential

por Tábi, Tamás, Vécsei, László, Youdim, Moussa B., Riederer, Peter, Szökő, Éva
Publicado 2019

Lewy bodies, iron, inflammation and neuromelanin: pathological aspects underlying Parkinson’s disease

por Riederer, Peter, Nagatsu, Toshiharu, Youdim, Moussa B. H., Wulf, Max, Dijkstra, Johannes M., Sian-Huelsmann, Jeswinder
Publicado 2023

Monoamine oxidase A upregulated by chronic intermittent hypoxia activates indoleamine 2,3-dioxygenase and neurodegeneration

por Lam, Chun-Sing, Li, Jing-Jie, Tipoe, George Lim, Youdim, Moussa B. H., Fung, Man-Lung
Publicado 2017

A Novel Antioxidant Multitarget Iron Chelator M30 Protects Hepatocytes against Ethanol-Induced Injury

por Xiao, Jia, Lv, Yi, Lin, Bin, Tipoe, George L., Youdim, Moussa B. H., Xing, Feiyue, Liu, Yingxia
Publicado 2015

M30 Antagonizes Indoleamine 2,3-Dioxygenase Activation and Neurodegeneration Induced by Corticosterone in the Hippocampus

por Lam, Chun-Sing, Tipoe, George Lim, Wong, Johnny Kong-Ching, Youdim, Moussa B. H., Fung, Man-Lung
Publicado 2016

Recent advances in amyotrophic lateral sclerosis research: perspectives for personalized clinical application

por Benkler, Chen, Offen, Daniel, Melamed, Eldad, Kupershmidt, Lana, Amit, Tamar, Mandel, Silvia, Youdim, Moussa B. H., Weinreb, Orly
Publicado 2010

The New Inhibitor of Monoamine Oxidase, M30, has a Neuroprotective Effect Against Dexamethasone-Induced Brain Cell Apoptosis

por Johnson, Shakevia, Tazik, Shawna, Lu, Deyin, Johnson, Chandra, Youdim, Moussa B. H., Wang, Junming, Rajkowska, Grazyna, Ou, Xiao-Ming
Publicado 2010

I(1) Imidazoline Receptor: Novel Potential Cytoprotective Target of TVP1022, the S-Enantiomer of Rasagiline

por Barac, Yaron D., Bar-Am, Orit, Liani, Esti, Amit, Tamar, Frolov, Luba, Ovcharenko, Elena, Angel, Itzchak, Youdim, Moussa B. H., Binah, Ofer
Publicado 2012

Correction: I(1) Imidazoline Receptor: Novel Potential Cytoprotective Target of TVP1022, the S-Enantiomer of Rasagiline

por Barac, Yaron D., Bar-Am, Orit, Liani, Esti, Amit, Tamar, Frolov, Luba, Ovcharenko, Elena, Angel, Itzchak, Youdim, Moussa B. H., Binah, Ofer
Publicado 2013

Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease

por Unzeta, Mercedes, Esteban, Gerard, Bolea, Irene, Fogel, Wieslawa A., Ramsay, Rona R., Youdim, Moussa B. H., Tipton, Keith F., Marco-Contelles, José
Publicado 2016